IL6 and obesity disorder: Thus, high circulating levels of IL-6 could reflect the intensity of obesity-associated chronic and systemic inflammation, which in turn might contribute to the development of atherosclerosis and CHD, both directly and by reducing HDL cholesterol levels [44].